Literature DB >> 16328968

The protective role of topical propolis on experimental keratitis via nitric oxide levels in rabbits.

N Duran1, A Koc, H Oksuz, C Tamer, Y Akaydin, T Kozlu, M Celik.   

Abstract

The aim of this study was to investigate antioxidant, anti-inflammatory, and antibacterial properties of propolis in the treatment of experimental Staphylococcus aureus keratitis. Twenty young New Zealand white rabbits were used in this experiment. Staphylococcus aureus were given by intrastromal injection to 16 rabbits and 4 rabbits were used as control group (Group 1). Group 2 was treated with phosphate-buffered solution drops; Group 3 was administered ethanolic extract of propolis drops; Group 4 received topical ciprofloxacin drops; Group 5 was treated with topical ciprofloxacin drops along with ethanolic extract of propolis drops. The eyes were examined by slit lamp to assess corneal opacity. And then, corneas were removed to determine nitric oxide (NO) levels and count bacteria. Corneas were also evaluated histologically. Corneal NO concentration in group 5, treated with a combination of propolis and ciprofloxacin was determined significantly lower (10.0+/- 1.8 micromol/g wet tissue) than in Group 4, treated with ciprofloxacin (24.0+/- 3.1 micromol/g wet tissue), from Group 3, treated with propolis (15.6+/- 1.8 micromol/g wet tissue), and treated with PBS (44.7+/- 7.8 micromol/g wet tissue). There were significantly fewer bacteria in eyes that received propolis plus ciprofloxacin than in eyes treated with ciprofloxacin (p = 0.0001) or propolis (p = 0.0001) or eyes treated with PBS (p = 0.0001). The light microscopic examination revealed that the control group showed normal corneal morphology. In the nontreated group, sections of the stromal infiltration revealed the presence of inflammatory cells, which were diffusely distributed (p < 0.05). Administrations of ciprofloxacin plus propolis resulted in a significantly reduced histological damage with fewer bacterial inoculation of the corneal stroma in comparison with the other groups (p < 0.05). Based on these findings, we suggest that ethanolic extract of propolis has antioxidant, anti-inflammatory, and antibacterial properties for S. aureus keratitis in rabbits.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16328968     DOI: 10.1007/s11010-006-0720-4

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  34 in total

Review 1.  Recent progress in pharmacological research of propolis.

Authors:  A H Banskota; Y Tezuka; S Kadota
Journal:  Phytother Res       Date:  2001-11       Impact factor: 5.878

2.  Antibacterial, antifungal, antiamoebic, antiinflammatory and antipyretic studies on propolis bee products.

Authors:  J W Dobrowolski; S B Vohora; K Sharma; S A Shah; S A Naqvi; P C Dandiya
Journal:  J Ethnopharmacol       Date:  1991-10       Impact factor: 4.360

3.  Free radical scavenging activity of propolis.

Authors:  Hisatsugu Ichikawa; Kazue Satoh; Takashi Tobe; Ichiro Yasuda; Fusao Ushio; Kenichiro Matsumoto; Kazutoyo Endo; Chiharu Ookubo
Journal:  Redox Rep       Date:  2002       Impact factor: 4.412

4.  Biochemical activities of propolis-extracts. III. Inhibition of dihydrofolate reductase.

Authors:  E Strehl; R Volpert; E F Elstner
Journal:  Z Naturforsch C J Biosci       Date:  1994 Jan-Feb

5.  Determination of inorganic nitrate in serum and urine by a kinetic cadmium-reduction method.

Authors:  N K Cortas; N W Wakid
Journal:  Clin Chem       Date:  1990-08       Impact factor: 8.327

6.  Experimental bacterial keratitis in neutropenic guinea pigs: polymorphonuclear leukocytes in corneal host defense.

Authors:  M J Chusid; S D Davis
Journal:  Infect Immun       Date:  1979-06       Impact factor: 3.441

7.  Inhibition of neutrophils' chemiluminescence by ethanol extract of propolis (EEP) and its phenolic components.

Authors:  W Krol; S Scheller; Z Czuba; T Matsuno; G Zydowicz; J Shani; M Mos
Journal:  J Ethnopharmacol       Date:  1996-12       Impact factor: 4.360

Review 8.  Nitric oxide in the eye: multifaceted roles and diverse outcomes.

Authors:  F Becquet; Y Courtois; O Goureau
Journal:  Surv Ophthalmol       Date:  1997 Jul-Aug       Impact factor: 6.048

9.  Alterations of ocular nitric oxide synthase in human glaucoma.

Authors:  J A Nathanson; M McKee
Journal:  Invest Ophthalmol Vis Sci       Date:  1995-08       Impact factor: 4.799

10.  Evidence for antiviral effect of nitric oxide. Inhibition of herpes simplex virus type 1 replication.

Authors:  K D Croen
Journal:  J Clin Invest       Date:  1993-06       Impact factor: 14.808

View more
  6 in total

1.  GC-MS analysis and antileishmanial activities of two Turkish propolis types.

Authors:  Nizami Duran; Mustafa Muz; Gulnaz Culha; Gulay Duran; Burcin Ozer
Journal:  Parasitol Res       Date:  2010-09-15       Impact factor: 2.289

2.  In vitro antileishmanial activity of Adana propolis samples on Leishmania tropica: a preliminary study.

Authors:  G Duran; N Duran; G Culha; B Ozcan; H Oztas; B Ozer
Journal:  Parasitol Res       Date:  2008-02-10       Impact factor: 2.289

Review 3.  Animal models of bacterial keratitis.

Authors:  Mary E Marquart
Journal:  J Biomed Biotechnol       Date:  2011-01-04

4.  Antiviral Activity of Hatay Propolis Against Replication of Herpes Simplex Virus Type 1 and Type 2.

Authors:  Ayse Yildirim; Gulay Gulbol Duran; Nizami Duran; Kemal Jenedi; Behiye Sezgin Bolgul; Meral Miraloglu; Mustafa Muz
Journal:  Med Sci Monit       Date:  2016-02-09

5.  Adjunctive Thymosin Beta-4 Treatment Influences MΦ Effector Cell Function to Improve Disease Outcome in Pseudomonas aeruginosa-Induced Keratitis.

Authors:  Yuxin Wang; Thomas W Carion; Abdul Shukkur Ebrahim; Gabriel Sosne; Elizabeth A Berger
Journal:  Int J Mol Sci       Date:  2021-10-13       Impact factor: 5.923

6.  Ophthalmic In Situ Gels with Balsam Poplar Buds Extract: Formulation, Rheological Characterization, and Quality Evaluation.

Authors:  Monika Stanciauskaite; Mindaugas Marksa; Liudas Ivanauskas; Kristina Perminaite; Kristina Ramanauskiene
Journal:  Pharmaceutics       Date:  2021-06-24       Impact factor: 6.321

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.